Cointime

Vedanta Biosciences

company

About

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.

  • 51 - 100

Highlights

Total Funding Amount
$111.99M
Funding Rounds
3
Investors
4

Details

Last Funding Type
Private Equity（PE）
Last Funding Money Raised
$50M
Industries
Biotechnology,Business Development,Medical
Founded date
Jan 1, 2010
Number Of Employee
51 - 100
Operating Status
Active

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.

It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$111.99M
Vedanta Biosciences has raised a total of $111.99M in funding over 2 rounds. Their latest funding was raised on Sep 23, 2019 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 23, 2019 Series C $16.60M 2 — — Detail
Dec 24, 2018 Series C $45.39M 1 — — Detail
Jun 6, 2016 Private Equity（PE） $50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
4
Vedanta Biosciences is funded by 4 investors. Shinhan Private Equity and FC Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Shinhan Private Equity — Series C
FC Capital — Series C
Invesco Asset Management — Series C
Invesco — Private Equity（PE）
Cointime
เนื้อหา
บริษัท